Zomedica Pharmaceuticals Corp.
(TSX Venture Exchange : ZOM)

( )
ZOM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Company
-0.02%45.321.4%$886.77m
MRKMerck & Co., Inc.
0.00%74.600.6%$868.71m
PFEPfizer Inc.
0.00%39.420.9%$823.54m
JNJJohnson & Johnson
0.00%139.900.7%$815.75m
LLYEli Lilly and Company
0.45%118.011.0%$666.22m
ABBVAbbVie, Inc.
0.74%79.232.2%$410.29m
NVSNovartis AG Sponsored ADR
3.23%78.350.2%$287.63m
AZNAstraZeneca PLC Sponsored ADR
0.70%38.961.3%$254.08m
GSKGlaxoSmithKline plc Sponsored ADR
0.03%40.220.2%$103.19m
NVONovo Nordisk A/S Sponsored ADR Class B
1.19%48.670.1%$67.15m
SNYSanofi Sponsored ADR
0.00%41.710.2%$36.01m
LCILannett Company, Inc.
-0.28%7.2036.7%$7.66m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.06%3.801.6%$5.61m
EPIXESSA Pharma Inc
-3.04%2.300.1%$0.03m

Company Profile

Zomedica Pharmaceuticals Corp. engages in the discovery, development and commercialization of pharmaceuticals for the companion pet. The company was founded by Gerald L. Solensky, Jr. on January 7, 2013 and is headquartered in Ann Arbor, MI.